CagA-dependent downregulation of B7-H2 expression on gastric mucosa and inhibition of Th17 responses during Helicobacter pylori infection

Journal of Immunology

Volumn 191, Issue 7, 2013, Pages 3838-3846

  Lina, Taslima T ^a   Pinchuk, Irina V ^a   House, Jennifer ^b   Yamaoka, Yoshio ^c   Graham, David Y ^c   Beswick, Ellen J ^d   Reyes, Victor E ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAGA PROTEIN; GAMMA INTERFERON; INDUCIBLE T CELL COSTIMULATOR LIGAND; S6 KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; CELL TYPE; CELLULAR IMMUNITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; IMMUNOPATHOLOGY; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; STOMACH EPITHELIUM; STOMACH MUCOSA; TH17 CELL;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CELL LINE; DOWN-REGULATION; FEMALE; GASTRIC MUCOSA; GENE EXPRESSION REGULATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INDUCIBLE T-CELL CO-STIMULATOR LIGAND; INTERFERON-GAMMA; MICE; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; TH17 CELLS; TOR SERINE-THREONINE KINASES;

EID: 84885115434     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300524     Document Type: Article

References (60)

1. Marshall, B. J. 1994. Helicobacter pylori. Am. J. Gastroenterol. 89(8, Suppl.):S116-S128.
2. Parsonnet, J., G. D. Friedman, D. P. Vandersteen, Y. Chang, J. H. Vogelman, N. Orentreich, and R. K. Sibley. 1991. Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med. 325:1127-1131.
3. Huang, J. Q., S. Sridhar, Y. Chen, and R. H. Hunt. 1998. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 114:1169-1179.
4. Uemura, N., S. Okamoto, S. Yamamoto, N. Matsumura, S. Yamaguchi, M. Yamakido, K. Taniyama, N. Sasaki, and R. J. Schlemper. 2001. Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. 345:784-789.
5. Parsonnet, J., S. Hansen, L. Rodriguez, A. B. Gelb, R. A. Warnke, E. Jellum, N. Orentreich, J. H. Vogelman, and G. D. Friedman. 1994. Helicobacter pylori infection and gastric lymphoma. N. Engl. J. Med. 330:1267-1271.
6. Rauws, E. A., and G. N. Tytgat. 1990. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 335:1233-1235.
7. Wu, X. C., P. Andrews, V. W. Chen, and F. D. Groves. 2009. Incidence of extranodal non-Hodgkin lymphomas among whites, blacks, and Asians/Pacific Islanders in the United States: anatomic site and histology differences. Cancer Epidemiol. 33:337-346.
8. Coghlan, J. G., D. Gilligan, H. Humphries, D. McKenna, C. Dooley, E. Sweeney, C. Keane, and C. O'Morain. 1987. Campylobacter pylori and recurrence of duodenal ulcers: a 12-month follow-up study. Lancet 330:1109-1111.
9. Blaser, M. J., and J. E. Crabtree. 1996. CagA and the outcome of Helicobacter pylori infection. Am. J. Clin. Pathol. 106:565-567.
10. Asahi, M., T. Azuma, S. Ito, Y. Ito, H. Suto, Y. Nagai, M. Tsubokawa, Y. Tohyama, S. Maeda, M. Omata, et al. 2000. Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells. J. Exp. Med. 191:593-602.
11. Bourzac, K. M., and K. Guillemin. 2005. Helicobacter pylori-host cell interactions mediated by type IV secretion. Cell. Microbiol. 7:911-919.
12. Hatakeyama, M. 2004. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat. Rev. Cancer 4:688-694.
13. Beswick, E. J., D. A. Bland, G. Suarez, C. A. Barrera, X. Fan, and V. E. Reyes. 2005. Helicobacter pylori binds to CD74 on gastric epithelial cells and stimulates interleukin-8 production. Infect. Immun. 73:2736-2743.
14. Müller, A., M. Oertli, and I. C. Arnold. 2011. H.pylori exploits and manipulates innate and adaptive immune cell signaling pathways to establish persistent infection. Cell Commun. Signal. 9:25.
15. Harris, P. R., S. W. Wright, C. Serrano, F. Riera, I. Duarte, J. Torres, A. Peña, A. Rollán, P. Viviani, E. Guiraldes, et al. 2008. Helicobacter pylori gastritis in children is associated with a regulatory T-cell response. Gastroenterology 134:491-499.
16. Mitchell, P., C. Germain, P. L. Fiori, W. Khamri, G. R. Foster, S. Ghosh, R. I. Lechler, K. B. Bamford, and G. Lombardi. 2007. Chronic exposure to Helicobacter pylori impairs dendritic cell function and inhibits Th1 development. Infect. Immun. 75:810-819.
17. Beswick, E. J., I. V. Pinchuk, R. B. Earley, D. A. Schmitt, and V. E. Reyes. 2011. Role of gastric epithelial cell-derived transforming growth factor b in reduced CD4+ T cell proliferation and development of regulatory T cells during Helicobacter pylori infection. Infect. Immun. 79:2737-2745.
18. Das, S., G. Suarez, E. J. Beswick, J. C. Sierra, D. Y. Graham, and V. E. Reyes. 2006. Expression of B7-H1 on gastric epithelial cells: its potential role in regulating T cells during Helicobacter pylori infection. J. Immunol. 176:3000-3009.
19. Kabir, S. 2011. The role of interleukin-17 in the Helicobacter pylori induced infection and immunity. Helicobacter 16:1-8.
20. Luzza, F., T. Parrello, G. Monteleone, L. Sebkova, M. Romano, R. Zarrilli, M. Imeneo, and F. Pallone. 2000. Up-regulation of IL-17 is associated with bioactive IL-8 expression in Helicobacter pylori-infected human gastric mucosa. J. Immunol. 165:5332-5337.
21. Resende, C., A. Thiel, J. C. Machado, and A. Ristimäki. 2011. Gastric cancer: basic aspects. Helicobacter 16(Suppl. 1):38-44.
22. De Lyria, E. S., R. W. Redline, and T. G. Blanchard. 2009. Vaccination of mice against H pylori induces a strong Th-17 response and immunity that is neutrophil dependent. Gastroenterology 136:247-256.
23. Kao, J. Y., M. Zhang, M. J. Miller, J. C. Mills, B. Wang, M. Liu, K. A. Eaton, W. Zou, B. E. Berndt, T. S. Cole, et al. 2010. Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. Gastroenterology 138:1046-1054.
24. Ishii, N., M. Chiba, M. Iizuka, H. Watanabe, T. Ishioka, and O. Masamune. 1992. Expression of MHC class II antigens (HLA-DR, -DP, and-DQ) on human gastric epithelium. Gastroenterol. Jpn. 27:23-28.
25. + T cell activation during Helicobacter pylori infection. J. Clin. Invest. 99:1628-1636.
26. Lenschow, D. J., T. L. Walunas, and J. A. Bluestone. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:233-258.
27. + FoxP3+ regulatory T cells. Infect. Immun. 75:4334-4341.
28. Aicher, A., M. Hayden-Ledbetter, W. A. Brady, A. Pezzutto, G. Richter, D. Magaletti, S. Buckwalter, J. A. Ledbetter, and E. A. Clark. 2000. Characterization of human inducible costimulator ligand expression and function. J. Immunol. 164:4689-4696.
29. Bauquet, A. T., H. Jin, A. M. Paterson, M. Mitsdoerffer, I. C. Ho, A. H. Sharpe, and V. K. Kuchroo. 2009. The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells. Nat. Immunol. 10:167-175.
30. Frey, O., J. Meisel, A. Hutloff, K. Bonhagen, L. Bruns, R. A. Kroczek, L. Morawietz, and T. Kamradt. 2010. Inducible costimulator (ICOS) blockade inhibits accumulation of polyfunctional T helper 1/T helper 17 cells and mitigates autoimmune arthritis. Ann. Rheum. Dis. 69:1495-1501.
31. Paulos, C. M., C. Carpenito, G. Plesa, M. M. Suhoski, A. Varela-Rohena, T. N. Golovina, R. G. Carroll, J. L. Riley, and C. H. June. 2010. The inducible costimulator (ICOS) is critical for the development of human TH17 cells. Sci. Transl. Med. 2:55ra78.
32. Fan, X., S. E. Crowe, S. Behar, H. Gunasena, G. Ye, H. Haeberle, N. Van Houten, W. K. Gourley, P. B. Ernst, and V. E. Reyes. 1998. The effect of class II major histocompatibility complex expression on adherence of Helicobacter pylori and induction of apoptosis in gastric epithelial cells: a mechanism for T helper cell type 1-mediated damage. J. Exp. Med. 187:1659-1669.
33. Crowe, S. E., L. Alvarez, M. Dytoc, R. H. Hunt, M. Muller, P. Sherman, J. Patel, Y. Jin, and P. B. Ernst. 1995. Expression of interleukin 8 and CD54 by human gastric epithelium after Helicobacter pylori infection in vitro. Gastroenterology 108:65-74.
34. Lu, H., J. Y. Wu, E. J. Beswick, T. Ohno, S. Odenbreit, R. Haas, V. E. Reyes, M. Kita, D. Y. Graham, and Y. Yamaoka. 2007. Functional and intracellular signaling differences associated with the Helicobacter pylori AlpAB adhesin from Western and East Asian strains. J. Biol. Chem. 282:6242-6254.
35. Arnold, I. C., J. Y. Lee, M. R. Amieva, A. Roers, R. A. Flavell, T. Sparwasser, and A. Müller. 2011. Tolerance rather than immunity protects from Helicobacter pylori-induced gastric preneoplasia. Gastroenterology 140:199-209.
36. Heuermann, D., and R. Haas. 1998. A stable shuttle vector system for efficient genetic complementation of Helicobacter pylori strains by transformation and conjugation. Mol. Gen. Genet. 257:519-528.
37. Saada, J. I., I. V. Pinchuk, C. A. Barrera, P. A. Adegboyega, G. Suarez, R. C. Mifflin, J. F. Di Mari, V. E. Reyes, and D. W. Powell. 2006. Subepithelial myofibroblasts are novel nonprofessional APCs in the human colonic mucosa. J. Immunol. 177:5968-5979.
38. Roussel, Y., A. Harris, M. H. Lee, and M. Wilks. 2007. Novel methods of quantitative real-time PCR data analysis in a murine Helicobacter pylori vaccine model. Vaccine 25:2919-2929.
39. Backert, S., and M. Selbach. 2008. Role of type IV secretion in Helicobacter pylori pathogenesis. Cell. Microbiol. 10:1573-1581.
40. Shimada, M., T. Ando, R. M. Peek, O. Watanabe, K. Ishiguro, O. Maeda, D. Ishikawa, M. Hasegawa, K. Ina, N. Ohmiya, et al. 2008. Helicobacter pylori infection upregulates interleukin-18 production from gastric epithelial cells. Eur. J. Gastroenterol. Hepatol. 20:1144-1150.
41. Churin, Y., L. Al-Ghoul, O. Kepp, T. F. Meyer, W. Birchmeier, and M. Naumann. 2003. Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response. J. Cell Biol. 161:249-255.
42. Higashi, H., A. Nakaya, R. Tsutsumi, K. Yokoyama, Y. Fujii, S. Ishikawa, M. Higuchi, A. Takahashi, Y. Kurashima, Y. Teishikata, et al. 2004. Helicobacter pylori CagA induces Ras-independent morphogenetic response through SHP-2 recruitment and activation. J. Biol. Chem. 279:17205-17216.
43. Lee, K. S., A. Kalantzis, C. B. Jackson, L. O'Connor, N. Murata-Kamiya, M. Hatakeyama, L. M. Judd, A. S. Giraud, and T. R. Menheniott. 2012. Helicobacter pylori CagA triggers expression of the bactericidal lectin REG3γ via gastric STAT3 activation. PLoS ONE 7:e30786.
44. + Helicobater pylori induces Akt1 phosphorylation and inhibits transcription of p21 (WAF1/CIP1) and p27 (KIP1) via PI3K/Akt1 pathway. Biomed. Environ. Sci. 23:273-278.
45. Crabtree, J. E., R. L. Ferrero, and J. G. Kusters. 2002. The mouse colonizing Helicobacter pylori strain SS1 may lack a functional cag pathogenicity island. Helicobacter 7:139-140.
46. Smythies, L. E., K. B. Waites, J. R. Lindsey, P. R. Harris, P. Ghiara, and P. D. Smith. 2000. Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-γ, gene-deficient mice. J. Immunol. 165:1022-1029.
47. Eaton, K. A., M. Mefford, and T. Thevenot. 2001. The role of T cell subsets and cytokines in the pathogenesis of Helicobacter pylori gastritis in mice. J. Immunol. 166:7456-7461.
48. Mohammadi, M., J. Nedrud, R. Redline, N. Lycke, and S. J. Czinn. 1997. Murine CD4 T-cell response to Helicobacter infection: TH1 cells enhance gastritis and TH2 cells reduce bacterial load. Gastroenterology 113:1848-1857.
49. Horvath, D. J., Jr., M. K. Washington, V. A. Cope, and H. M. Algood. 2012. IL-23 contributes to control of chronic Helicobacter pylori infection and the development of T helper responses in a mouse model. Front. Immunol. 3:56.
50. Burmeister, Y., T. Lischke, A. C. Dahler, H. W. Mages, K. P. Lam, A. J. Coyle, R. A. Kroczek, and A. Hutloff. 2008. ICOS controls the pool size of effectormemory and regulatory T cells. J. Immunol. 180:774-782.
51. Kadkhoda, K., S. Wang, A. G. Joyee, Y. Fan, J. Yang, and X. Yang. 2010. Th1 cytokine responses fail to effectively control Chlamydia lung infection in ICOS ligand knockout mice. J. Immunol. 184:3780-3788.
52. Nakazawa, A., I. Dotan, J. Brimnes, M. Allez, L. Shao, F. Tsushima, M. Azuma, and L. Mayer. 2004. The expression and function of costimulatory molecules B7H and B7-H1 on colonic epithelial cells. Gastroenterology 126:1347-1357.
53. Kusters, J. G., A. H. van Vliet, and E. J. Kuipers. 2006. Pathogenesis of Helicobacter pylori infection. Clin. Microbiol. Rev. 19:449-490.
54. Karttunen, R., T. Karttunen, H. P. Ekre, and T. T. MacDonald. 1995. Interferon γ and interleukin 4 secreting cells in the gastric antrum in Helicobacter pylori positive and negative gastritis. Gut 36:341-345.
55. Kim, J., A. C. Myers, L. Chen, D. M. Pardoll, Q. A. Truong-Tran, A. P. Lane, J. F. McDyer, L. Fortuno, and R. P. Schleimer. 2005. Constitutive and inducible expression of B7 family of ligands by human airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 33:280-289.
56. Morgado, P., Y. C. Ong, J. C. Boothroyd, and M. B. Lodoen. 2011. Toxoplasma gondii induces B7-2 expression through activation of JNK signal transduction. Infect. Immun. 79:4401-4412.
57. Stanciu, L. A., C. M. Bellettato, V. Laza-Stanca, A. J. Coyle, A. Papi, and S. L. Johnston. 2006. Expression of programmed death-1 ligand (PD-L) 1, PD-L2, B7-H3, and inducible costimulator ligand on human respiratory tract epithelial cells and regulation by respiratory syncytial virus and type 1 and 2 cytokines. J. Infect. Dis. 193:404-412.
58. Fingar, D. C., C. J. Richardson, A. R. Tee, L. Cheatham, C. Tsou, and J. Blenis. 2004. mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E. Mol. Cell. Biol. 24:200-216.
59. O'Rourke, J. L., and A. Lee. 2003. Animal models of Helicobacter pylori infection and disease. Microbes Infect. 5:741-748.
60. Czinn, S. J., and T. Blanchard. 2011. Vaccinating against Helicobacter pylori infection. Nat. Rev. Gastroenterol. Hepatol. 8:133-140.